Navigation Links
Singulex Closes $19 Million Financing Round
Date:1/12/2009

ALAMEDA, Calif., Jan. 12 /PRNewswire/ -- Singulex, Inc. today announced that it has closed a $19 million financing round, led by JAFCO Co., Ltd. and supported by existing investors including OrbiMed Advisors and Fisk Ventures. The financing round will support the commercialization of Singulex technologies in the diagnostics market. As part of the financing, Hironori Hozoji, investment officer for JAFCO Life Science Investment, will join the company's Board of Directors.

"With these funds, we are confident we have the resources to develop our immunoassay technology for use in the diagnostics field," said Philippe Goix, PhD, CEO of Singulex. "Already, the assays we have developed and optimized for our pharmaceutical partners have enabled them to see biomarker level differences in blood samples with and without drugs that they had not been able to see before, thus offering new insights for their clinical trials."

Singulex has closed partnerships with multiple large pharmaceutical companies to use Erenna technology and immunoassays to help them better understand the effects of their compounds early in preclinical studies and clinical trials. With its ability to detect and measure minute protein biomarker changes at very low levels, Singulex's technology also has significant potential for clinical applications in personalized medicine across multiple diseases.

Singulex will use the funds from this financing to deploy its product and services in the emerging molecular clinical diagnostic market. Initially, the company will focus on cardiovascular disease risk diagnostics using its assay platform for the biomarker c Troponin I (cTnI), a well-validated marker for cardiac necrosis.

"Singulex's steady progress in publishing strong data from premier medical schools in the country indicated that the Erenna technology can make significant contributions to the diagnostics field, specifically in the cardiov
'/>"/>

SOURCE Singulex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program
2. Karolinska Development Closes Fully Subscribed New Share Issue
3. Concentric Medical Closes on $15 Million Financing
4. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
5. Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing
6. AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
7. MicroPhage Closes Latest Financing
8. Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing
9. CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
10. Starfish Ventures Closes Australias Largest Venture Capital Fund With $185 Million Tech Fund
11. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...RNewswire-FirstCall/ - Microbix Biosystems Inc. (t... the Form 52-109F1 Certification of Annual Filings...d James Long, the Chief Financial Officer (the "Of...onnection with the annual audited financial statem...The Company initially filed the annual financial s...
(Date:11/6/2009)... Nov. 6 ,, 3Q09 Co... Qutenza(TM) E.U. Marketing Authorization to Astel... in commercial readiness activities Expanded mana...Marketing; and Director, Commercial Operations Ap...nd Audit Committee chairman , Upcoming 2009...
(Date:11/5/2009)...one hybrid . . . , Fuel economy ratings for th...t the www.fueleconomy.gov web site, which Oak Ri...r the U.S. Department of Energy and the U.S. Envir...icles on the best fuel economy list are hybrid ele...ighway). "This list proves that hybrids have gone ...
(Date:11/5/2009)...lif., Nov. 5 ThermoGenes...nnovative products for processing and storing adul... quarter of fiscal 2010. ,, For the quarter end...es of $5.2 million, a 15 percent increase over rev...ago. The Company said the key contributors to the ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
.... April 20 Advanced Instruments, Inc . today i...mometer as the first true automation-friendly osmo...e Advanced(R) 2020-BIO Multi-Sample Osmometer ...efines -- automation capabilities for osmolality t...Kelly Peterson, Product Manager, Advanced Instrume...
...N, April 20 Santaris Pharma announced today,promi... of microRNA-targeted,therapeutics against cancer ...ucleic Acid (LNA) Drug Platform. In both in vitro ...ed LNA-antimiR(R),s demonstrated outstanding,recog...NAs due to their high,specificity and affinity. Th...
...ril 20 Psylin Neurosciences Inc., a joint ventu...ceuticals, Inc. and PsychoGenics, Inc. announced t...t of a novel compound, PSN0041, for the treatment ...com/cgi-bin/prnh/20090420/LA01157LOGO ) , , PS...tide hormone library, PHORMOL, was identified as h...
Other Biology Technology:Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 2Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutical Industry 3LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs 2Psylin Neurosciences Commences Development of Compound for Depression 2Psylin Neurosciences Commences Development of Compound for Depression 3
(Date:11/6/2009)...sary this month of the publication of On the Origi... Sciences (AIBS) is publishing open access two pee...istoric insights into evolution. , The two articl...rnia, Berkeley, and James T. Costa of Western Caro...t Charles Darwin," appeared in the October issue o...
(Date:11/6/2009)...9) The Monell Center and the Chinese Academy of S...ional Meeting on Taste and Smell Research. Organiz...eting will be the first international meeting on t...er, Chief Executive Officer, American Association ...sher of Science magazine, will open the meeting wi...
(Date:11/5/2009)... awarded a training grant in the amount of $2,756,...ntegrative Graduation Education and Research Train... to be awarded to Kent State. The grant, which is ...t Act of 2009, runs through 2014. , The grant fu...quatic resource sensing (EARS). The purpose of the...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Mayo Clinic physician receives first PASSOR Legacy Award 60163 1New American Chemical Society podcast 3A Tiny sea creature and a new medical adhesive 10546 1Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 1Stanford researchers awarded 246 27 million to study energy efficiency and human behavior 10541 2
...ll needs both to build new and to degrade old or d...ntracellular systems work in concert to keep the c...eins. When proteins or peptides mutate, they can p...tracellular environment. In Huntington,s disease (...in gene eventually causes the cell to build up int...
...cientists has announced a major expansion of a lin...s in living organisms. The expansion provides ter... events that occur when a pathogenic or beneficial...events is crucial for developing new interventions...obes while preserving or encouraging the presence ...
...they won,t be able to understand the brain until t...how billions of neurons are interconnected. Now, r...udies have jumped what many believe to be a major ... the connections to a single neuron. , In the Marc...escribe how they modified the deadly rabies virus,...
Other Biology News:Proteasome activator enhances survival of Huntington's disease neuronal model cells 2Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3
Plastic Glove Boxes from Terra Universal, Inc.
...w Hummingbird has the ability to quickly and accur...kes it a perfect candidate for inclusion in these ...CX interface supplied with all the Cartesian produ...ore. Hummingbirds ability to copy plates in secon...
Exhaust Fume Hood from Terra Universal, Inc.
...bel IT siRNA Tracker Intracellular Localization Ki... label and deliver siRNA, of your design, in an ef...racking experiments. Subcellular localization and ...n be monitored following introduction of the label...
Biology Products: